Pharmacokinetics of a fusion protein for human acidic fibroblast growth factor and transcriptional activator protein in rat and its penetration across blood-brain barrier

Yaoxue Xuebao

Volumn 46, Issue 10, 2011, Pages 1204-1208

  Yang, Peng Hui ^a   Xu, Hua ^a   Zhang, Qi Hao ^a   Li, Juan ^a   Xiong, Yao Ling ^a   Huang, Ya Dong ^a   Su, Zhi Jian ^a   Zheng, Qing ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Acidic fibroblast growth factor; Alzheimer's disease; Blood brain barrier; Pharmacokinetics; Transcriptional activator protein

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; HYBRID PROTEIN; TAT HAFGF HYBRID PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG PENETRATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HALF LIFE TIME; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PHARMACOKINETICS; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELL NUCLEUS; CEREBRAL CORTEX; FEMALE; FIBROBLAST GROWTH FACTOR 1; GENE PRODUCTS, TAT; HIPPOCAMPUS; INJECTIONS, INTRAVENOUS; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS;

EID: 83455258046     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Wu JC, Huang WC, Tsai YA, et al. Nerve repair using acidic fibroblast growth factor in human cervical spinal cord injury: a preliminary Phase I clinical study [J]. J Neurosurg Spine, 2008, 8: 208-214.
2. Reuss B, von Bohlenund Halbach O. Fibroblast growth factors and their receptors in the central nervous system [J]. Cell Tissue Res, 2003, 313: 139-157.
3. Maccioni RB, Lavados M, Maccioni CB, et al. Biological markers of Alzheimer's disease and mild cognitive impairment [J]. Curr Alzheimer Res, 2004, 1: 307-314.
4. Cai B, Lin Y, Xue XH, et al. TAT-mediated delivery of neuroglobin protects against focal cerebral ischemia in mice [J]. Exp Neurol, 2011, 227: 224-231.
5. Katsura K, Takahashi K, Asoh S, et al. Combination therapy with transductive anti-death FNK protein and FK506 ameliorates brain damage with focal transient ischemia in rat [J]. J Neurochem, 2008, 106: 258-270. (Pubitemid 351840209)
6. Cao G, Pei W, Ge H, et al. In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis [J]. J Neurosci, 2002, 22: 5423-5431. (Pubitemid 35386464)
7. Kilic U, Kilic E, Dietz G, et al. Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice [J]. Stroke, 2003, 34: 1304-1310. (Pubitemid 36547533)
8. Li T, Fan Y, Luo Y, et al. In vivo delivery of a XIAP (BIR3-RING) fusion protein containing the protein transduction domain protects against neuronal death induced by seizures [J]. Exp Neurol, 2006, 197: 301-308. (Pubitemid 43077137)
9. Nagel F, Falkenburger BH, Tonges L, et al. Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease [J]. J Neurochem, 2008, 105: 853-864. (Pubitemid 351562740)
10. Lin JC, Zhang MJ, Su ZJ, et al. Expression, purification and bioassay of Tat-aFGF fusion protein in Escherichia coli [J]. China Biotechnol, 2010, 30: 11-17.
11. Ren J, Qin CG, Xu CL, et al. Development of cell-penetrating peptides as vectors for drug delivery [J]. Acta Pharm Sin, 2010, 45: 17-25.
12. Wang XF, Zheng Q. The methodology and experimental design in pharmacokinetics study of biotechnological drugs [J]. China Biotechnol, 2004, 24: 80-83.
13. 19-154 [J]. Appl Microbiol Biotechnol, 2008, 77: 1015-1022.
14. 1H NMR structural characterization of a nonmitogenic, vasodilatory, ischemia-protector and neuromodulatory acidic fibroblast growth factor [J]. Biochemistry, 2000, 39: 4982-4993.
15. Wu SP, Fu AL, Wang YX, et al. A novel therapeutic approach to 6-OHDA-induced Parkinson's disease in rats via supplementation of PTD-conjugated tyrosine hydroxylase [J]. Biochem Biophys Res Commun, 2006, 346: 1-6. (Pubitemid 43865960)
16. Li XK, Xu H, Zhao W, et al. Pharmacokinetic study of recombinant human acidic fibroblast growth factor in rabbits by skin external use [J]. Acta Pharm Sin, 2002, 37: 424-427.
17. Duchardt F, Fotin-Mleczek M, Schwarz H, et al. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides [J]. Traffic, 2007, 8: 848-866. (Pubitemid 46971632)